These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36662904)

  • 1. United in Big Data? Exploring scholars' opinions on academic-industry partnership and the use of corporate data in digital behavioral research.
    Favaretto M; De Clercq E; Caplan A; Elger BS
    PLoS One; 2023; 18(1):e0280542. PubMed ID: 36662904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First do no harm: An exploration of researchers' ethics of conduct in Big Data behavioral studies.
    Favaretto M; De Clercq E; Gaab J; Elger BS
    PLoS One; 2020; 15(11):e0241865. PubMed ID: 33152039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.
    Dresser R
    Theor Med Bioeth; 2006; 27(2):115-39. PubMed ID: 16699963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Disclosure: Developing Law and Policy to Tackle Corporate Influence.
    Marks JH
    Am J Law Med; 2020 May; 46(2-3):275-296. PubMed ID: 32659196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The connection between academia and industry.
    Singh A; Singh S
    Mens Sana Monogr; 2005 Mar; 3(1):5-35. PubMed ID: 22679346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting User Privacy and Rights in Academic Data-Sharing Partnerships: Principles From a Pilot Program at Crisis Text Line.
    Pisani AR; Kanuri N; Filbin B; Gallo C; Gould M; Lehmann LS; Levine R; Marcotte JE; Pascal B; Rousseau D; Turner S; Yen S; Ranney ML
    J Med Internet Res; 2019 Jan; 21(1):e11507. PubMed ID: 30664452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It depends:" a qualitative study on digital health academic-industry collaboration.
    Ford KL; Leiferman J; Sobral B; Bennett JK; Moore SL; Bull S
    Mhealth; 2021; 7():57. PubMed ID: 34805388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical implications of for-profit corporate sponsorship of research.
    Cichy KA
    SRA J; 1990; 22(1):23-7. PubMed ID: 16047436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of corporate social responsibility.
    Bergman SM; Vernillo AT
    J Am Coll Dent; 2014; 81(1):41-5. PubMed ID: 25080670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working Through Ethics Review of Big Data Research Projects: An Investigation into the Experiences of Swiss and American Researchers.
    Favaretto M; De Clercq E; Briel M; Elger BS
    J Empir Res Hum Res Ethics; 2020 Oct; 15(4):339-354. PubMed ID: 32552544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
    Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
    Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic management and organizational culture of medical device companies in relation to corporate performance.
    Park S; Kim HK; Lee HJ; Choi M; Lee M; Jakovljevic M
    J Med Econ; 2023; 26(1):781-792. PubMed ID: 37300440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.
    Dănescu T; Popa MA
    Global Health; 2020 Dec; 16(1):117. PubMed ID: 33302949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "We're already doing this work": ethical research with community-based organizations.
    Fielding-Miller R; Kim S; Bowles J; Streuli S; Davidson P
    BMC Med Res Methodol; 2022 Sep; 22(1):237. PubMed ID: 36056309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.